Pure Global AI
CDSCO UID IMP/IVD/2020/000060_fa3d76b43503c8f04968674c28245954_0d3f82e57d1c251bfeaf819983da0165

MAGLUMI Direct Renin

M/s. Golden Harvest IndustriesDevice Class Class BIndia CDSCOBrand: CLIA
VerifiedCDSCO · official registry
Registration details
UID
IMP/IVD/2020/000060_fa3d76b43503c8f04968674c28245954_0d3f82e57d1c251bfeaf819983da0165
Device class
Class B
Brand name
CLIA
Approving authority
CDSCO
Product information
The kit is an in vitro chemiluminescent immunoassay for the quantitative determination of Renin in human EDTA-plasma specimens using the MAGLUMI series Fully-auto chemiluminescence immunoassay analyzer (CLIA)
About this record

MAGLUMI Direct Renin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000060_fa3d76b43503c8f04968674c28245954_0d3f82e57d1c251bfeaf819983da0165. This device is marketed under the brand name CLIA. The license holder is M/s. Golden Harvest Industries, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides the facts attached to this CDSCO registry row. Other records from the same license holder are available through the database search link without adding aggregation queries to this page. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.